Risk, risk, risk. Ensure that risk analysis is thorough. There are many, many cases of adverse events reported so the FDA knows the risks associated with infusion pumps and if you haven't identified and mitigated them, you will have issues.
At one point, the FDA had said they were going to require safety / assurance case analysis. I don't know if they ever enforced that or not.